As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research team has proposed a cutting-edge research strategy that leverages artificial ...

Jia’s team developed a protocol to improve the screening of protein pockets. This involved identifying the pockets, removing ...

Fully open source model accurately predicts the 3D structures of proteins and biomolecules in silico, and serves as a foundational model for next generation of cutting-edge Protein AI tools The ...

The MarketWatch News Department was not involved in the creation of this content. -- Genesis' proprietary foundation model -- Pearl -- outperforms frontier models, including AlphaFold 3, on key ...

We know the genes, but not their functions." To resolve this long-standing bottleneck in microbial research, a joint research team has proposed a ...

Rapid, structure-free binding affinity prediction enables OpenFold3 to address key bottleneck in commercial early-stage drug discovery PALO ALTO, Calif., Jan. 20, 2026 /PRNewswire/ -- SandboxAQ today ...

A research team reports that advances in protein design—especially when combined with artificial intelligence—are rapidly ...

Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...

Researchers have harnessed AI to expedite the creation of lightbulb-like intrabody probes that can track activity in living ...